Nils Lycke
Director/Board Member at MIVAC Development AB
Profile
Nils Lycke is the founder of Toleranzia AB, which was founded in 2012.
He held the title of Director & Chief Scientific Officer from 2012 to 2018.
Dr. Lycke's current jobs include being a Director at MIVAC Development AB, a Director at Loni Medicals Aktiebolag, a Professor at the University of Gothenburg, and a Chief Physician at Sahlgrenska Universitetssjukhuset.
He previously worked as a Director at Gotimmune AB.
Nils Lycke active positions
Companies | Position | Start |
---|---|---|
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Director/Board Member | - |
University of Gothenburg | Corporate Officer/Principal | 01/06/2011 |
Sahlgrenska Universitetssjukhuset
Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Corporate Officer/Principal | - |
Loni Medicals Aktiebolag | Director/Board Member | - |
Former positions of Nils Lycke
Companies | Position | End |
---|---|---|
TOLERANZIA AB | Founder | 16/01/2018 |
Gotimmune AB
Gotimmune AB Pharmaceuticals: MajorHealth Technology Gotimmune AB develops treatment for Helicobacter pylori. The company is headquartered in Goteborg, Sweden. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TOLERANZIA AB | Health Technology |
Private companies | 4 |
---|---|
Sahlgrenska Universitetssjukhuset
Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Health Services |
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Health Technology |
Gotimmune AB
Gotimmune AB Pharmaceuticals: MajorHealth Technology Gotimmune AB develops treatment for Helicobacter pylori. The company is headquartered in Goteborg, Sweden. | Health Technology |
Loni Medicals Aktiebolag |
- Stock Market
- Insiders
- Nils Lycke